Boston Scientific reorganizes into three segments under new COO
FROM THE WIRE · FINANCE.YAHOO.COM
Boston Scientific (NYSE: BSX) appointed Joseph M. Fitzgerald as executive vice president and chief operating officer, effective January 1, 2027. The company plans to reorganize its global operations into three reportable segments: Interventional Therapies, Rhythm Solutions, and…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: neutralBoston Scientific appoints Joseph Fitzgerald as COO effective January 1, 2027, and reorganizes into three reportable segments.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Joseph M. Fitzgerald appointed executive vice president and COO effective January 1, 2027.
- 02Company reorganizes into three reportable segments: Interventional Therapies, Rhythm Solutions, and MedSurg.
- 03Fitzgerald will oversee the transition to the new segment structure as part of broader operational realignment.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets